cGMP-compliance, Scale Out and Cost Efficiency. Enabling the transition from your manual protocol to an automated process.
Empowering your ATMP manufacturing with Automation, Flexibility, Integrated Imaging and Remote Monitoring.
The evolution of automated cell expansion systems for mid- up to large-scale batch sizes. Maximum flexibility in cell expansion for clinical and commercial Advanced Therapies manufacturing needs.
Seamless transition from R&D to clinical and commercial manufacturing. Automated cell expansion for small- to mid-scale batches, ideal for autologous and redistributed scale-out manufacturing.
Your cell factory dashboard. A range of Apps to help you monitor and manage all your NANT Systems from one easy, centralized and convenient interface.
FDA Authorizes ImmunityBio to Conduct a Trial of its First-in-Human, Cryopreserved, Memory Cytokine-Enriched NK Cell (m-ceNK) Platform in Solid Tumors
ImmunityBio, Inc. announced it has received FDA authorization to conduct a Phase 1 study to evaluate the safety and preliminary efficacy of its m-ceNK platform in subjects with locally advanced or metastatic solid tumors. Read more 〉
VivaBioCell is now a partner of the Centre for Advanced Medical Products (CAMP) - Sweden
We're very proud to be the first international partner of the Centre for Advanced Medical Products (CAMP), making our technology available to develop new innovative therapeutic applications in Sweden. Read more 〉
Automated GMP cell expansion: Manufacturing solutions for sustainable therapeutic applications - A webinar by VivaBioCell and Prof. Frank Barry (Scientific Director, Regenerative Medicine Institute, Galway – Ireland)
You can now watch the full recording of VivaBioCell webinar Automated GMP cell expansion: Manufacturing solutions for sustainable therapeutic applications, providing insights on how NANT 001 and NANT XL Systems can improve GMP-compliant automated cell therapy manufacturing. Read more 〉